Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland

Yves Jackson1,2, Drenusha Vieira de Mello Pula1, Axel Finckh3

  • 1Geneva University Hospitals and University of Geneva, Division of Primary Care Medicine, Geneva, Switzerland.

Insights

This study found no clinical link between Chagas disease and systemic autoimmune diseases in Bolivian migrants. Further research in endemic areas is needed to explore any potential relationship with Chagasic cardiomyopathy.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Rheumatology
  • Public Health

Background:

  • Chagas disease affects 20-40% of patients with chronic cardiomyopathy.
  • Autoimmune mechanisms are implicated in Chagasic cardiomyopathy pathogenesis.
  • Systemic autoimmune diseases were observed in Bolivian migrants with high Chagas disease prevalence.

Purpose of the Study:

  • To investigate a potential clinical association between systemic autoimmune diseases and Chagas disease.
  • To determine if Chagas disease is linked to the development of cardiomyopathy.

Main Methods:

  • Retrospective analysis of medical records of Bolivian patients at Geneva University Hospitals (2012-2015).
  • Inclusion criteria: diagnosis of Chagas disease or systemic autoimmune diseases.
  • Data collected on patient demographics, Chagas status, and autoimmune disease diagnosis.

Main Results:

  • 28 out of 2,189 patients (1.3%) had systemic autoimmune disease.
  • 244 out of 903 patients (27.0%) tested positive for Chagas disease.
  • No significant association was found between Chagas disease and systemic autoimmune diseases (p=1.000) or Chagasic cardiomyopathy (p=0.729).

Conclusions:

  • Current findings do not support a clinical association between chronic Chagas disease and systemic autoimmune diseases.
  • Prospective studies in Chagas-endemic regions are recommended to better evaluate the prevalence of systemic autoimmune diseases and their relationship with Chagas infection.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
987
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
585
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
588